Distributional Impact of Higher Patient Contributions to Australia's Pharmaceutical Benefits Scheme

Australian Health Review - Australia
doi 10.1071/ah000032
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

CSIRO Publishing

Related search

Php120 - What Do We Stand to Lose? The Proportion of Us-Owned Pharmaceuticals on Australia’s Pharmaceutical Benefits Scheme

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Distributional Effects of Higher Unemployment

Brookings Papers on Economic Activity
AccountingManagementEconomicsEconometricsBusiness
1974English

Time Trends in Adrenaline Auto-Injector Dispensing Patterns Using Australian Pharmaceutical Benefits Scheme Data

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

The Pharmaceutical Price Regulation Scheme

BMJ
2007English

The Veterans’ Valorisation Scheme: Marginalising Women’s Contributions to the Resistance

2015English

The External Benefits of Higher Education

Regional Studies
Social SciencesEnvironmental Science
2016English

Higher Order Hadronic and Leptonic Contributions to the Muong− 2

EPJ Web of Conferences
AstronomyPhysics
2016English

Higher-Order Hadronic Contributions to the Anomalous Magnetic Moment of Leptons

Physics Letters, Section B: Nuclear, Elementary Particle and High-Energy Physics
High Energy PhysicsNuclear
1997English

Modeling Higher Twist Contributions to Deep Inelastic Scattering With Diquarks

Zeitschrift für Physik C: Particles and Fields
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy